Lyon, IARC Press, 2022. 27. Mandahl N, Mertens F Soft Tissue Tumors. In: Heim S, Mitelman F, editors. Cancer Cytogenetics, 3rd edition. New York, Wiley-Blackwell, 675711. 28. Gisselsson D, Hibbard MK, Dal Cin P, Sciot R, Hsi BL, et al. PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell forms and proof for alternative oncogenic mechanisms. Am J Pathol 159: 955962. 29. Ropke A, Kalinski T, Kluba U, von Falkenhausen U, Wieacker PF, et al. PLAG1 activation in lipoblastoma coinciding with low-level amplification of a six Transcriptional Activation of PLAG1 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. derivative chromosome 8 having a deletion del. Cytogenet Genome Res 119: 3338. Bartuma H, Domanski HA, Von Steyern FV, Kullendorff CM, Mandahl N, et al. Cytogenetic and molecular cytogenetic findings in lipoblastoma. Cancer Genet Cytogenet 183: 6063. Pedeutour F, 58-49-1 Deville A, Steyaert H, Ranchere-Vince D, Ambrosetti D, et al. Rearrangement of HMGA2 within a case of infantile lipoblastoma with no Plag1 alteration. 18325633 Pediatr Blood Cancer 58: 798800. Belge G, Meyer A, Klemke M, Burchardt K, Stern C, et al. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish in between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47: 5663. Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, et al. HMGA2 mRNA expression correlates with all the malignant phenotype in human thyroid neoplasias. Eur J Cancer 44: 10151021. Lappinga PJ, Kip NS, Jin L, Lloyd RV, Henry MR, et al. HMGA2 gene expression evaluation performed on cytologic smears to distinguish benign from malignant thyroid nodules. Cancer Cytopathol 118: 287297. Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, et al. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR. Diagn Mol Pathol 20: 7180. Prasad NB, Somervell H, Tufano RP, Dackiw AP, Marohn MR, et al. Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res 14: 33273337. Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, et al. Adverse regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 23: 22252238. Mussnich P, D’Angelo D, Leone V, Croce CM, Fusco A The Higher Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression. Mol Oncol 7: 531542. Klemke M, Meyer A, Nezhad MH, Bartnitzke S, Drieschner N, et al. Overexpression of HMGA2 in uterine leiomyomas points to its basic function for the pathogenesis of your disease. Genes Chromosomes Cancer 48: 171178. Markowski DN, Bartnitzke S, Belge G, Drieschner N, Helmke BM, et al. Cell culture and senescence in uterine fibroids. Cancer Genet Cytogenet 202: 5357. Markowski DN, Helmke BM, Radtke A, Froeb J, Belge G, et al. Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium. BMC Womens Well being 12: 2. Schaffer LG, Slovak ML, Campbell LJ, editors ISCN 2009: an international technique for human cytogenetic nomenclature. Basel, S. Karger. Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, et al. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17: 413418. Brants JR, Ayoubi TA, Chada K, Marchal K, Van de Ven WJ, et al. Differential regulation.